Patent · US Active

Composition and method for treating tinnitus

US9770433B2 · kind B2 · utility

1Cited by

17References

24Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Josef Miller · Ann Arbor, US
Glenn E. Green · Dexter, US
Barry S. Seifer · Ann Arbor, US

Key dates

Filing date	Sep 8, 2015
Grant date	Sep 26, 2017
Priority date	—
Expiry date	Sep 8, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating tinnitus includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.